Diagnostic Accuracy of MRI and Additional [ 18 F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Background: Neuroimaging has a reasonable accuracy to differentiate behavioral variant frontotemporal dementia (bvFTD) from other neurodegenerative disorders, its value for the differentiation of bvFTD among subjects with acquired behavioral disturbances is unknown. Objective: To determine the diagnostic accuracy of MRI, additional [ 18 F]FDG-PET, and their combination for bvFTD among subjects with late onset behavioral changes. Methods: Patients with late onset behavioral changes referred to a memory clinic or psychiatric services were included. At baseline, 111 patients had a brain MRI scan and 74 patients received an additional [ 18 F]FDG-PET when the MRI was inconclusive. The consensus diagnosis after two-year-follow-up was used as the gold standard to calculate sensitivity and specificity for baseline neuroimaging. Results: 27 patients had probable/definite bvFTD and 84 patients had a non-bvFTD diagnosis (primary psychiatric diagnosis or other neurological disorders). MRI had a sensitivity of 70% (95% CI 52–85%) with a specificity of 93% (95% CI 86–97%). Additional [ 18 F]FDG-PET had a sensitivity of 90% (95% CI 66–100%) with a specificity of 68% (95% CI 56–79%). The sensitivity of combined neuroimaging was 96% (95% CI 85–100%) with a specificity of 73% (95% CI 63–81%). In 66% of the genetic FTD cases, MRI lacked typical frontotemporal atrophy. 40% of cases with a false positive [ 18 F]FDG-PET scan had a primary psychiatric diagnosis. Conclusion: A good diagnostic accuracy was found for MRI and additional [ 18 F]FDG-PET for bvFTD in patients with late onset behavioral changes. Caution with the interpretation of neuroimaging results should especially be taken in cases with a genetic background and in cases with a primary psychiatric differential diagnosis where [ 18 F]FDG-PET is the only abnormal investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“Cognitive screening tests included the Mini-Mental State Examination (MMSE) [21] and the Frontal Assessment Battery (FAB) [22].”
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · cited 1×
“Psychiatric evaluation included applying the Montgomery Aberg Depression Rating Scale (MADRS) [23] for depressive symptoms, the positive and negative symptom scale for psychotic symptoms (PANSS) [24], and the MINI-PLUS Diagnostic interview [25] to assess primary psychiatric disorders.”
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · cited 1×
“Diagnoses were based on the published consensus guidelines for dementia and the primary psychiatric diagnoses were based on current psychiatric criteria [4, 29–33].”
Self-citationA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 1×
“Psychiatric evaluation included applying the Montgomery Aberg Depression Rating Scale (MADRS) [23] for depressive symptoms, the positive and negative symptom scale for psychotic symptoms (PANSS) [24], and the MINI-PLUS Diagnostic inter-view [25] to assess primary psychiatric disorders.”
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J., Alavi, A., Hurtig, H., & Zimmerman, R. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,334
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 2×
“As described in the international consensus criteria for bvFTD (FTDC), the presence of frontotemporal abnormalities on neuroimaging is considered as a biomarker for bvFTD, and is mandatory for the diagnosis probable bvFTD [4].”
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141 · cited 1×
“Diagnoses were based on the published consensus guidelines for dementia and the primary psychiatric diagnoses were based on current psychiatric criteria [4, 29–33].”
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913 · cited 1×
“Cognitive screening tests included the Mini-Mental State Examination (MMSE) [21] and the Frontal Assessment Battery (FAB) [22].”
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · cited 2×
“This also may be explained by the synaptic dysfunction in primary psychiatric disorders in similar anatomic regions as bvFTD [10–15].”
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110 · cited 1×
“…( n = 3), progressive supranuclear palsy ( n = 1), and cortical basal syndrome ( n = 1) patients had false positive neuroimaging, since these disorders are all part of the frontotemporal lobar degeneration spectrum and have partially overlapping atrophy and hypometabolism patterns [50, 51].”
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608 · cited 1×
“Frontotemporal changes on [18F]FDG-PET had a high sensitivity for bvFTD, similar to previous studies [5, 46].”
Anatomy of bipolar disorder and schizophrenia: A meta-analysis
Ellison-Wright, I., & Bullmore, E. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.022 · Cited by 565 · cited 2×
“This also may be explained by the synaptic dysfunction in primary psychiatric disorders in similar anatomic regions as bvFTD [10–15].”
Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L., & Rankin, K. P. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06382oli · Cited by 549
Scheltens, P., Launer, L. J., Barkhof, F., Weinstein, H. C., & Gool, W. A. (1995) · Journal of Neurology · doi:10.1007/bf00868807 · Cited by 472 · cited 1×
“…of hippocampus), and white matter hyperintensities (WMH) (Fazekas) using 4 point scale (0 = None or a single punctate WMH lesion; 1 = Multiple punc-tate lesions; 2 = Beginning confluences of lesions; 3 = Large confluent lesions), according to established and validated visual rating scales [26–28].”
Self-citationVisual assessment of posterior atrophy development of a MRI rating scale
Koedam, E. L. G. E., Lehmann, M., van der Flier, W. M., Scheltens, P., Pijnenburg, Y. A. L., Fox, N., Barkhof, F., & Wattjes, M. P. (2011) · European Radiology · doi:10.1007/s00330-011-2205-4 · Cited by 413
Self-citation11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Rabinovici, G. D., Furst, A. J., O'Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L., Chetty, S., Patel, P., Pagliaro, T. A., Klunk, W. E., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259035.98480.ed · Cited by 410
Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
van der Flier, W. M., Pijnenburg, Y. A. L., Prins, N., Lemstra, A. W., Bouwman, F. H., Teunissen, C. E., van Berckel, B. N. M., Stam, C. J., Barkhof, F., Visser, P. J., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132306 · Cited by 398 · cited 2×
“The patients had been referred to the VU medical center Alzheimer Center and the Department of Old Age Psychiatry of the GGZInGeest, Amsterdam, the Netherlands, between April 2011 and June 2013 [18].”
Self-citationChanges in Cortical Thickness During the Course of Illness in Schizophrenia
van Haren, N. E. M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.88 · Cited by 378 · cited 2×
“This also may be explained by the synaptic dysfunction in primary psychiatric disorders in similar anatomic regions as bvFTD [10–15].”
Regional brain volume in depression and anxiety disorders
van Tol, M.-J., van der Wee, N. J. A., van den Heuvel, O. A., Nielen, M. M. A., Demenescu, L. R., Aleman, A., Renken, R., van Buchem, M. A., Zitman, F. G., & Veltman, D. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.121 · Cited by 370 · cited 2×
“This also may be explained by the synaptic dysfunction in primary psychiatric disorders in similar anatomic regions as bvFTD [10–15].”
Kadekaro, M., Crane, A. M., & Sokoloff, L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.6010 · Cited by 337 · cited 1×
“An explanation for these results might by the early synaptic dysfunction in the frontal and temporal regions in bvFTD [47], which is measured by [18F]FDG-PET [48].”
The frontal behavioral inventory in the differential diagnosis of frontotemporal dementia
KERTESZ, A., NADKARNI, N., DAVIDSON, W., & THOMAS, A. W. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700644041 · Cited by 317 · cited 1×
“Patients were included in the study when behavioral complaints dominated the presentation and when they had a score of≥ 11 on the Frontal Behavioural Inventory (FBI) [19] or a score of≥ 10 on the Stereotypy Rating Inventory (SRI) [20].”
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
Schoonenboom, N. S. M., Reesink, F. E., Verwey, N. A., Kester, M. I., Teunissen, C. E., van de Ven, P. M., Pijnenburg, Y. A. L., Blankenstein, M. A., Rozemuller, A. J., Scheltens, P., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31823ed0f0 · Cited by 302
Self-citationRegional cerebral glucose utilization in patients with a range of severities of unipolar depression
Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., Willis, M. W., Herscovitch, P., & Post, R. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01216-1 · Cited by 301 · cited 2×
“Several studies have reported evidence of changes in frontotemporal regions on MRI and [ 18 F]FDG-PET-scan in mood disorders and schizophrenia [10–15], primary psychiatric disorders that may also presentwithbehavioralchanges.”
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease
Frisoni, G. B., Laakso, M. P., Beltramello, A., Geroldi, C., Bianchetti, A., Soininen, H., & Trabucchi, M. (1999) · Neurology · doi:10.1212/wnl.52.1.91 · Cited by 285 · cited 1×
“In addition, the current findings also seem in line with previous studies that found higher MTA scores in FTD [40–42].”
MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases
Harper, L., Fumagalli, G. G., Barkhof, F., Scheltens, P., O’Brien, J. T., Bouwman, F., Burton, E. J., Rohrer, J. D., Fox, N. C., Ridgway, G. R., et al. (2016) · Brain · doi:10.1093/brain/aww005 · Cited by 264
Self-citationBeck, J., Rohrer, J. D., Campbell, T., Isaacs, A., Morrison, K. E., Goodall, E. F., Warrington, E. K., Stevens, J., Revesz, T., Holton, J., et al. (2008) · Brain · doi:10.1093/brain/awm320 · Cited by 230 · cited 1×
“Moreover, 3 cases with a definite bvFTD had atypical findings on MRI [35, 36].”
Accuracy of the Clinical Evaluation for Frontotemporal Dementia
Mendez, M. F., Shapira, J. S., McMurtray, A., Licht, E., & Miller, B. L. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.830 · Cited by 205 · cited 2×
“Frontotemporal changes on [ 18 F]FDG-PET had a high sensitivity for bvFTD, similar to previous studies [5, 46].”
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease
van de Pol, L. A. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.075341 · Cited by 191 · cited 1×
“In addition, the current findings also seem in line with previous studies that found higher MTA scores in FTD [40–42].”
Self-citationTemporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia
Galton, C. J. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.2.165 · Cited by 188 · cited 1×
“In addition, the current findings also seem in line with previous studies that found higher MTA scores in FTD [40–42].”
Antemortem diagnosis of frontotemporal lobar degeneration
Knopman, D. S., Boeve, B. F., Parisi, J. E., Dickson, D. W., Smith, G. E., Ivnik, R. J., Josephs, K. A., & Petersen, R. C. (2005) · Annals of Neurology · doi:10.1002/ana.20425 · Cited by 188
Khan, B. K., Yokoyama, J. S., Takada, L. T., Sha, S. J., Rutherford, N. J., Fong, J. C., Karydas, A. M., Wu, T., Ketelle, R. S., Baker, M. C., et al. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301883 · Cited by 185 · cited 1×
“This might be due to the atypical slow progression of this phenotype of bvFTD [49].”
Kipps, C. M., Davies, R. R., Mitchell, J., Kril, J. J., Halliday, G. M., & Hodges, J. R. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100973 · Cited by 172 · cited 1×
“Our results seem to be more consistent with a sensitivity of 72% of MRI in a different cohort of patients carrying a C9orf72 hexanucleotide repeat expansion [38] and a sensitivity of 75% in clinically defined bvFTD [39].”
Frontotemporal Dementia Associated With the C9ORF72 Mutation: A Unique Clinical Profile
Devenney, E., Hornberger, M., Irish, M., Mioshi, E., Burrell, J., Tan, R., Kiernan, M. C., & Hodges, J. R. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6002 · Cited by 167 · cited 2×
“In contrast, other studies found lower sensitivities for [18F]FDG-PET in patients with a C9orf72 hexanucleotide repeat expansion [37, 38].”
(1999) · PubMed · Cited by 142
Whitwell, J. L., Boeve, B. F., Weigand, S. D., Senjem, M. L., Gunter, J. L., Baker, M. C., DeJesus‐Hernandez, M., Knopman, D. S., Wszolek, Z. K., Petersen, R. C., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12675 · Cited by 119 · cited 1×
“Moreover, 3 cases with a definite bvFTD had atypical findings on MRI [35, 36].”
The Stereotypy Rating Inventory for frontotemporal lobar degeneration
Shigenobu, K., Ikeda, M., Fukuhara, R., Maki, N., Hokoishi, K., Nebu, A., Yasuoka, T., Komori, K., & Tanabe, H. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00094-x · Cited by 105 · cited 1×
“Patients were included in the study when behavioral ≥ 11 on the Frontal Behavioural Inventory (FBI) [19] or a score of ≥ 10 on the Stereotypy Rating Inventory (SRI) [20].”
Hosokawa, T., Momose, T., & Kasai, K. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.014 · Cited by 104 · cited 2×
“Several studies have reported evidence of changes in frontotemporal regions on MRI and [ 18 F]FDG-PET-scan in mood disorders and schizophrenia [10–15], primary psychiatric disorders that may also presentwithbehavioralchanges.”
Ducharme, S., Price, B. H., Larvie, M., Dougherty, D. D., & Dickerson, B. C. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101248 · Cited by 98 · cited 1×
“Identifying the specific cause of late-onset behavioral changes represents a major challenge [1–3] and will be increasingly important when disease-specific treatments become available.”
Lipton, A. M., Cullum, C. M., Satumtira, S., Sontag, E., Hynan, L. S., White III, C. L., & Bigio, E. H. (2001) · Archives of Neurology · doi:10.1001/archneur.58.8.1233 · Cited by 73 · cited 1×
“An explanation for these results might by the early synaptic dysfunction in the frontal and temporal regions in bvFTD [47], which is measured by [18F]FDG-PET [48].”
Gossink, F. T., Dols, A., Kerssens, C. J., Krudop, W. A., Kerklaan, B. J., Scheltens, P., Stek, M. L., & Pijnenburg, Y. A. L. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308284 · Cited by 64
Self-citation18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
Kobylecki, C., Langheinrich, T., Hinz, R., Vardy, E. R. L. C., Brown, G., Martino, M.-E., Haense, C., Richardson, A. M., Gerhard, A., Anton-Rodriguez, J. M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147454 · Cited by 47 · cited 1×
“Biomarkers aiming at detecting underlying amyloid pathology, such as amyloid PET imaging [43, 44] and cerebrospinal fluid amyloid beta [45] could serve this goal.”
Pijnenburg, Y. A. L., Mulder, J. L., van Swieten, J. C., Uitdehaag, B. M. J., Stevens, M., Scheltens, P., & Jonker, C. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000112852 · Cited by 47 · cited 3×
“In a previous study including clinical frontotemporal lobar degeneration syndrome cases, it was found that only 50% had abnormalities on the MRI at presentation using postmortem confirmed diagnosis as gold standard [6, 8].”
Self-citationKerklaan, B. J., van Berckel, B. N. M., Herholz, K., Dols, A., van der Flier, W. M., Scheltens, P., & Pijnenburg, Y. A. L. (2014) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317514524811 · Cited by 46
Self-citationThe phenotype of the C9ORF72 expansion carriers according to revised criteria for bvFTD
Solje, E., Aaltokallio, H., Koivumaa-Honkanen, H., Suhonen, N. M., Moilanen, V., Kiviharju, A., Traynor, B., Tienari, P. J., Hartikainen, P., & Remes, A. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131817 · Cited by 46 · cited 2×
“Our results seem to be more consistent with a sensitivity of 72% of MRI in a different cohort of patients carrying a C9orf72 hexanucleotide repeat expansion [38] and a sensitivity of 75% in clinically defined bvFTD [39].”
Krudop, W. A., Kerssens, C. J., Dols, A., Prins, N. D., Möller, C., Schouws, S. N. T. M., Barkhof, F., van Berckel, B. N. M., Teunissen, C. E., van der Flier, W. M., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.02.002 · Cited by 44 · cited 3×
“Additional information of the assessment is described in the LOF study design [17].”
InfluentialSelf-citationIdentifying bvFTD within the wide spectrum of late onset frontal lobe syndrome: a clinical approach
Krudop, W. A., Kerssens, C. J., Dols, A., Prins, N. D., Möller, C., Schouws, S., van der Flier, W. M., Scheltens, P., Sikkes, S., Stek, M. L., et al. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.04.002 · Cited by 33 · cited 1×
“Therefore, the aim of this study was to measure the diagnostic accuracy of MRI and additional [ 18 F]FDG-PET for bvFTD in a large and clinically relevant cohort, consisting of subjects with late-onset behavioral changes [16].”
Self-citationCHARACTERIZING RADIOLOGY REPORTS IN PATIENTS WITH FRONTOTEMPORAL DEMENTIA
Suárez, J., Tartaglia, M. C., Vitali, P., Erbetta, A., Neuhaus, J., Laluz, V., & Miller, B. L. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b9c8a6 · Cited by 31 · cited 1×
“Although clinical classification of neuroimaging can be poor [52], in the majority of studies visual rating is reliable and correlates with atrophy of the dementia pathology [53].”
Antidepressants in Older Adults: Complexities, Confounds and Clinical Effects
Devanand, D. P., & Roose, S. P. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.09.008 · Cited by 4
Research works printed but not linked: 2
- American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders 4th edition Text Revision (DSM-IV-TR) American Psychiatric Association Washington DC.
- 10.1159/000100973 · DOI · Paper page
Cited by
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Amsterdam Dementia Cohort: Performing Research to Optimize Care
van der Flier, W. M., & Scheltens, P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170850 · Cited by 390
Self-citationDucharme, S., Dols, A., Laforce, R., Devenney, E., Kumfor, F., van den Stock, J., Dallaire-Théroux, C., Seelaar, H., Gossink, F., Vijverberg, E., et al. (2020) · Brain · doi:10.1093/brain/awaa018 · Cited by 320
Self-citationBoeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y., & Rohrer, J. D. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00341-0 · Cited by 218
Self-citationImaging and fluid biomarkers in frontotemporal dementia
Meeter, L. H., Kaat, L. D., Rohrer, J. D., & van Swieten, J. C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.75 · Cited by 210
Metadata
- Authors
- Vijverberg, E. G. B., Wattjes, M. P., Dols, A., Krudop, W. A., Möller, C., Peters, A., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., van Berckel, B. N. M., Barkhof, F., & Pijnenburg, Y. A. L.
- Affiliations
- Amsterdam Neuroscience (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- GGZ inGeest (NL)
- Leiden University (NL)
- Department of Nuclear Medicine & PET research, VU University Medical Centre, Amsterdam, The Netherlands
- Corresponding author
- Vijverberg, Everard G.B.
- ORCID
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-06-30
- Volume
- 53
- Issue
- 4
- Pages
- 1287-1297
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2505161130
- Cited by
- 92
- References
- 53
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 18 · 2023: 7 · 2022: 7 · 2021: 14 · 2020: 11 · 2019: 5 · 2018: 8 · 2017: 6
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Vanderbilt University Medical Center
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- behavioral variant frontotemporal dementia, diagnostic accuracy
- MeSH terms
- Aged, Atrophy, Mental Disorders, Brain, False Negative Reactions, False Positive Reactions, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Sensitivity and Specificity, Age of Onset, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Frontotemporal Dementia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.